June 3, 2017 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Bristol-Myers Squibb and QIAGEN Sign Agreement for Use of NGS Technology to Develop Gene Expression Profiles for Immuno-Oncology Therapies

NEW YORK and HILDEN, Germany, (June 3, 2017) – Bristol-Myers Squibb Company (NYSE: BMY) and QIAGEN(NASDAQ: QGEN; Frankfurt Prime Standard: QIA) have signed an agreement to explore the use of next-generation sequencing (NGS) technology to develop gene expression profiles (GEPs) as  predictive or prognostic tools for  use with Bristol-Myers Squibb novel immuno-oncology (I-O) therapies in... Read more

June 2, 2017 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Agilent Technologies and Agendia Sign Agreement on Molecular Cancer Diagnostics

Agreement Accelerates the Development of Tests to Help Assess Risk of Disease Recurrence in Women with Early-Stage Breast Cancer SANTA CLARA, Calif., June 2, 2017 Agilent Technologies Inc. (NYSE: A) and Agendia, Inc. today jointly announced an agreementto expand their relationship to include the development of an RNA-Seq kit version of Agendia’s currently marketed MammaPrint... Read more

June 1, 2017 Cell Analysis Tools Chromatography Clinical Research/Diagn. Mass Spectrometry PR/Corporate

SCIEX Announces Innovative Solutions for Customer Success Across Markets at ASMS 2017

Industry leader brings to the forefront customer innovations for routine and advanced workflows that are changing the LC-MS landscape. June 01, 2017 Framingham, MA — SCIEX, a global leader in life science analytical technologies, today announced that at ASMS 2017, it will highlight the cutting-edge innovations developed to power their most advanced LC-MS instrumentation and... Read more

June 1, 2017 Clinical Research/Diagn. Lab Top-10 Product Launch

Bruker Introduces New Solutions for Microbial Strain Typing, Hospital Hygiene and Infection Control at the ASM Microbe 2017 Meeting

NEW ORLEANS, June 1, 2017 /PRNewswire/ — At the American Society for Microbiology (ASM) Microbe 2017 meeting (www.asm.org), Bruker introduces major innovations for strain typing, hospital hygiene and infection control. The novel, bench-top IR Biotyper system for microbial strain typing is based on Fourier-Transform Infrared (FTIR) spectroscopy technology, and complements Bruker’s world-leading MALDI Biotyper mass... Read more

June 1, 2017 Bio/Pharma/CRO Clinical Research/Diagn.

Announcement on submission of the Clinical Trial Plan Notification for phase I clinical trial of Oncolytic virus HF10 against pancreatic cancer in Japan

2017 2017/06/01 Announcement on submission of the Clinical Trial Plan Notification for phase I clinical trial of Oncolytic virus HF10 against pancreatic cancer in Japan Kusatsu/Shiga, Japan — Jun 1, 2017 — Takara Bio Inc. (Takara Bio) announced that the Clinical Trial Notification was submitted to PMDA (Pharmaceuticals and Medical Devices Agency; Japanese regulatory agency)... Read more

June 1, 2017 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Philips and Illumina team up with Navican, an Intermountain Healthcare Company, to Accelerate the Delivery of Precision Medicine to Health Systems Worldwide

– New “turnkey” approach to precision medicine seeks to deliver Intermountain’s best practices into a streamlined service to be integrated at the point of care – Solution’s goal is to benefit late stage cancer patients through advanced analytics and expert decision support, combined with providing better access to targeted treatments and clinical trials NEWS PROVIDED... Read more

May 29, 2017 Bio/Pharma/CRO Clinical Research/Diagn.

First patient enrolled into Oncolytic Virus HF10 phase II clinical trial in Japan

2017 2017/05/29 First patient enrolled into Oncolytic Virus HF10 phase II clinical trial in Japan Kusatsu/Shiga, Japan — May 29, 2017 — Takara Bio Inc. (Takara Bio), today announced that the first patient with melanoma has been enrolled into Oncolytic Virus HF10(TBI-1401) phase II clinical trial in Japan on May 26, 2017. In this clinical study,... Read more

May 25, 2017 Clinical Research/Diagn. PR/Corporate

Luminex Corporation To Present At Jefferies 2017 Global Healthcare Conference

AUSTIN, Texas, May 25, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) announced today that management will present at the Jefferies 2017 Global Healthcare Conference on Thursday, June 8 at 8:30am ET in New York. The investor presentation will be webcast live and may be accessed at Luminex Corporation’s website at http://www.luminexcorp.com. Simply log on to the web at... Read more

May 24, 2017 Clinical Research/Diagn. Mass Spectrometry Product Launch

SCIEX Announces the First FDA-Cleared Vitamin D Assay Kit for Mass Spectrometry

SCIEX Vitamin D 200M Assay for the TopazTM System designed to measure Vitamin D with greater accuracy and simplicity for In Vitro Diagnostic (IVD) analysis in clinical diagnostic labs May 24, 2017 Framingham, MA — SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry,... Read more